NCIC Clinical Trials Group
ctg.queensu.caTotal trials
116
Active
0
Phase 3
40
Total enrollment
39,944
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Breast Cancer19
- Lung Cancer14
- Unspecified Adult Solid Tumor, Protocol Specific13
- Prostate Cancer13
- Lymphoma11
- Colorectal Cancer7
- Ovarian Cancer6
- Head and Neck Cancer5
Frequently asked questions about NCIC Clinical Trials Group
- How many clinical trials does NCIC Clinical Trials Group have on ClinicalTrials.gov?
- NCIC Clinical Trials Group is listed as the lead sponsor on 116 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of NCIC Clinical Trials Group's trials are in Phase 3?
- 40 of NCIC Clinical Trials Group's trials are in Phase 3.
- What therapeutic areas does NCIC Clinical Trials Group focus on?
- NCIC Clinical Trials Group's most-studied conditions on ClinicalTrials.gov are Breast Cancer, Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific, Prostate Cancer, Lymphoma.